MedTrace Logo

Creatine Supplementation in Pediatric Rheumatology

NCT01217320 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-01-16

No results posted yet for this study

Summary

Creatine supplementation may improve strength, muscle mass, bone mass and muscle function in healthy and elderly people. The investigators speculate that creatine supplementation could have therapeutic effects in pediatric rheumatic (i.e., juvenile systemic lupus erythematosus and juvenile dermatomyositis) patients who usually present muscle weakness, muscle wasting and bone mass loss.

Conditions

  • Juvenile Systemic Lupus Erythematosus
  • Juvenile Dermatomyositis

Interventions

DIETARY_SUPPLEMENT

creatine

5g/d throughout 12 weeks

DIETARY_SUPPLEMENT

placebo (dextrose)

5g/d throughout 12 weeks

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Bruno Gualano, PhD · University of Sao Paulo

  • Eloisa Bonfa, MD, PhD · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01217320 on ClinicalTrials.gov